Posted by Michael Wonder on 04 Jan 2021
NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st
4 January 2020 - Companies can now submit medicines for the new Innovative Licensing and Access Pathway following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.
The new route for the approval of medicines aims to smooth the journey from clinical trials through to NHS patients through closer collaboration and planning between the agencies involved in each step.
It will mean NHS patients will have access to innovative new medicines sooner.
